enVVeno Medical Corp - NVNO
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 20, 2026 | SCHEDULE 13D | — | 5.05% | 655,606 | View |
| Feb 20, 2026 | SCHEDULE 13D | — | 5.05% | 655,606 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 9.99% | 2,048,515 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Joseph Edelman | 9.99% | 2,048,515 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 2,048,515 | View |
| Feb 10, 2026 | SCHEDULE 13G | Northstrive Fund II LP | 3.07% | 20,129 | View |
| Feb 10, 2026 | SCHEDULE 13G | Braeden Lichti | 5.05% | 33,151 | View |
| Feb 10, 2026 | SCHEDULE 13G | Braeden Lichti | 5.05% | 33,151 | View |
| Feb 10, 2026 | SCHEDULE 13G | Northstrive Fund II LP | 3.07% | 20,129 | View |
| Nov 19, 2025 | SCHEDULE 13G | Thomas A. Satterfield, Jr. | 9.0% | 1,822,500 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 3.46% | 688,940 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Wilmot B. Harkey | 3.46% | 688,940 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Daniel Mack | 3.46% | 688,940 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.